Bromide

Bromide

SCHEMBL305729

CCCCCCCCCCCCCC[P+](CCCCCC)(CCCCCC)CCCCCC.[Br-]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 1/20 0.41
DNM1 Q05193 8/20 0.94
TSHR P16473 3/20 0.53
THRB P10828 1/20 0.53
BDKRB2 P30411 2/20 0.48
ALDH1A1 P00352 2/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
ALOX15 P16050 1/20 0.45
ALOX12 P18054 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HIF1A Q16665 1/20 0.45
HSD17B10 Q99714 1/20 0.45
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5088099 1.00 DNM1 (0.94) DNM1TSHRTHRBBDKRB2ALDH1A1
Bromide SCHEMBL5085435 1.00 DNM1 (0.94) DNM1TSHRTHRBBDKRB2ALDH1A1
Bromide SCHEMBL5088155 1.00 DNM1 (0.94) DNM1TSHRTHRBBDKRB2ALDH1A1
Bromide SCHEMBL5086648 1.00 DNM1 (0.94) DNM1TSHRTHRBBDKRB2ALDH1A1
Bromide SCHEMBL5092640 1.00 DNM1 (0.94) DNM1TSHRTHRBBDKRB2ALDH1A1
Bromide SCHEMBL5088225 1.00 DNM1 (0.94) DNM1TSHRTHRBBDKRB2ALDH1A1
Bromide SCHEMBL5087904 1.00 DNM1 (0.94) DNM1TSHRTHRBBDKRB2ALDH1A1
Bromide SCHEMBL5091705 1.00 DNM1 (0.94) DNM1TSHRTHRBBDKRB2ALDH1A1
Bromide SCHEMBL5088633 1.00 DNM1 (0.94) DNM1TSHRTHRBBDKRB2ALDH1A1
Bromide SCHEMBL5086877 1.00 DNM1 (0.94) DNM1TSHRTHRBBDKRB2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 564 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3275039-B1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF CORP (US) 2025-08-27 EP claimed
US-12344784-B2 Stabilized perovskite quantum dot material QUANTUM ADVANCED SOLUTIONS LIMITED (GB) 2025-07-01 US claimed
CN-111718716-B Nanostructure with inorganic ligands for electroluminescent devices 昭荣化学工业株式会社 2025-06-10 CN claimed
CN-119681278-A Preparation method of Pt-rare earth nano alloy based on ionic liquid 中国科学院过程工程研究所 2025-03-25 CN claimed
US-20250041798-A1 VERSATILE SCRUBBING LIQUID FOR REMOVAL OF CONTAMINANTS FROM A GASEOUS STREAM CLAIRION LTD. (IL) 2025-02-06 US claimed
CN-119350290-A Method for preparing 1, 4-dioxane-2-ketone from ethylene carbonate 青岛科技大学 2025-01-24 CN claimed
EP-4440727-A1 VERSATILE SCRUBBING LIQUID FOR REMOVAL OF CONTAMINANTS FROM A GASEOUS STREAM Clairion Ltd. (IL) 2024-10-09 EP claimed
CN-117482706-A Solid acid catalyzed ionic liquid CO 2 Method for desorbing rich liquid 中国石油大学(北京) 2024-02-02 CN claimed
US-11845735-B2 Method for synthesizing (RS)-Warfarin BATOOIE NASIM (IR) 2023-12-19 US claimed
US-11788171-B2 Methods of recovering an elemental rare earth metal, and methods of forming a rare earth metal BATTELLE ENERGY ALLIANCE, LLC (US) 2023-10-17 US claimed
WO-2011090611-A2 PROCESS FOR REMOVING SULFUR FROM VACUUM GAS OIL UOP LLC (US) 2011-07-28 WO claimed
WO-2011081764-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED IONIC LIQUID CYTEC TECHNOLOGY CORP. (US) 2011-07-07 WO claimed
US-20110155637-A1 PROCESS FOR REMOVING NITROGEN FROM VACUUM GAS OIL UOP LLC (US) 2011-06-30 US claimed
US-20110155638-A1 PROCESS FOR REMOVING SULFUR FROM VACUUM GAS OIL UOP LLC (US) 2011-06-30 US claimed
US-20110140037-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED ORGANIC SALT CYTEC TECHNOLOGY CORP. (US) 2011-06-16 US claimed
EP-1778705-A4 PHOSPHONIUM IONIC LIQUIDS AS RECYCLABLE SOLVENTS FOR SOLUTION PHASE CHEMISTRY UNIV FRASER SIMON (CA) 2008-12-31 EP claimed
US-20080258113-A1 Phosphonium Ionic Liquids as Recyclable Solvents for Solution Phase Chemistry SIMON FRASER UNIVERSITY (CA) 2008-10-23 US claimed
US-20070215865-A1 Opto-electronic devices exhibiting enhanced efficiency GENERAL ELECTRIC COMPANY (US) 2007-09-20 US claimed
EP-1778705-A1 PHOSPHONIUM IONIC LIQUIDS AS RECYCLABLE SOLVENTS FOR SOLUTION PHASE CHEMISTRY SIMON FRASER UNIVERSITY (CA) 2007-05-02 EP claimed
WO-2006007703-A1 PHOSPHONIUM IONIC LIQUIDS AS RECYCLABLE SOLVENTS FOR SOLUTION PHASE CHEMISTRY SIMON FRASER UNIVERSITY (CA) 2006-01-26 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080258113-A1 Phosphonium Ionic Liquids as Recyclable Solvents for Solution Phase Chemistry PLA2G2C, NUDT1, GNAI2 OPRM1 3593/4885DNM1 3341/4885TSHR 4128/4885
US-20110140037-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF IMPURITIES FROM AN IMPURITY-LOADED ORGANIC SALT OSTC, SLC10A6, SLC22A8 OPRM1 524/4885DNM1 1084/4885TSHR 4622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.